Gene-Editing Shot Cuts "Bad" Cholesterol 62% in Trial

A one-time gene-editing treatment slashed bad cholesterol by 62% in early human trials, offering hope for millions who struggle with heart disease prevention.

Eli Lilly's breakthrough therapy showed no serious side effects in the study.